Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
- Author
- SAFAEIAN, Mahboobeh1 ; PORRAS, Carolina2 ; HERRERO, Rolando2 4 ; KEMP, Troy1 ; SHELTON, Gloriana1 ; QUINT, Wim3 ; VAN DOOM, Leen-Jan3 ; HILDESHEIM, Allan1 ; PINTO, Ligia A1 ; YUANJI PAN1 ; KREIMER, Aimee1 ; SCHILLER, John T1 ; GONZALEZ, Paula2 4 ; LOWY, Douglas R1 ; WACHOLDER, Sholom1 ; SCHIFFMAN, Mark1 ; RODRIGUEZ, Ana C2
[1] National Cancer Institute, NIH, Bethesda, Maryland, United States
[2] Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Costa Rica
[3] DDL Diagnostic Laboratory, Voorburg, Netherlands
[4] Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France
CVT Group - Source
Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 11, pp 1242-1250, 9 p ; ref : 30 ref
- ISSN
- 1940-6207
- Scientific domain
- Medical oncology; Hygiene and public health, epidemiology, occupational medicine
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticorps Dose Essai clinique Immunité humorale Papillomavirus humain Particule type viral Réponse immune Vaccin Virose Protéine CAM L1 Costa Rica Infection Papillomavirus Papovaviridae Virus Amérique Centrale Amérique
- Keyword (en)
- Antibody Dose Clinical trial Humoral immunity Human papillomavirus Virus like particle Immune response Vaccine Viral disease Cell adhesion molecule L1 Costa Rica Infection Papillomavirus Papovaviridae Virus Central America America
- Keyword (es)
- Anticuerpo Dosis Ensayo clínico Inmunidad humoral Human papillomavirus Partícula tipo vírico Respuesta inmune Vacuna Virosis Proteína CAM L1 Costa Rica Infección Papillomavirus Papovaviridae Virus America central America
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B30 Public health. Hygiene-occupational medicine / 002B30A Public health. Hygiene / 002B30A03 Prevention and actions / 002B30A03C Miscellaneous
- Discipline
- Infectious pathology Public health. Hygiene-occupational medicine
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27921944
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/1940-6207.CAPR-13-0203 
https://dx.doi.org/10.1158/1940-6207.CAPR-13-0203
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1158\/1940-6207.CAPR-13-0203\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Cancer prevention research (Philadelphia, Pa.)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Cancer prev. res. (Phila., Pa.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1242\";s:8:\"\u0000*\u0000epage\";s:4:\"1250\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1940-6207\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SAFAEIAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Mahboobeh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"PORRAS, Carolina\";i:1;s:16:\"HERRERO, Rolando\";i:2;s:10:\"KEMP, Troy\";i:3;s:17:\"SHELTON, Gloriana\";i:4;s:10:\"QUINT, Wim\";i:5;s:18:\"VAN DOOM, Leen-Jan\";i:6;s:17:\"HILDESHEIM, Allan\";i:7;s:14:\"PINTO, Ligia A\";i:8;s:10:\"YUANJI PAN\";i:9;s:14:\"KREIMER, Aimee\";i:10;s:16:\"SCHILLER, John T\";i:11;s:15:\"GONZALEZ, Paula\";i:12;s:15:\"LOWY, Douglas R\";i:13;s:17:\"WACHOLDER, Sholom\";i:14;s:15:\"SCHIFFMAN, Mark\";i:15;s:16:\"RODRIGUEZ, Ana C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1158\/1940-6207.CAPR-13-0203\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Cancer prevention research (Philadelphia, Pa.)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Cancer prev. res. (Phila., Pa.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1242\";s:8:\"\u0000*\u0000epage\";s:4:\"1250\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1940-6207\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SAFAEIAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Mahboobeh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"PORRAS, Carolina\";i:1;s:16:\"HERRERO, Rolando\";i:2;s:10:\"KEMP, Troy\";i:3;s:17:\"SHELTON, Gloriana\";i:4;s:10:\"QUINT, Wim\";i:5;s:18:\"VAN DOOM, Leen-Jan\";i:6;s:17:\"HILDESHEIM, Allan\";i:7;s:14:\"PINTO, Ligia A\";i:8;s:10:\"YUANJI PAN\";i:9;s:14:\"KREIMER, Aimee\";i:10;s:16:\"SCHILLER, John T\";i:11;s:15:\"GONZALEZ, Paula\";i:12;s:15:\"LOWY, Douglas R\";i:13;s:17:\"WACHOLDER, Sholom\";i:14;s:15:\"SCHIFFMAN, Mark\";i:15;s:16:\"RODRIGUEZ, Ana C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:30:\"10.1158\/1940-6207.CAPR-13-0203\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1158\/1940-6207.CAPR-13-0203\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Cancer prevention research (Philadelphia, Pa.)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Cancer prev. res. (Phila., Pa.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1242\";s:8:\"\u0000*\u0000epage\";s:4:\"1250\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1940-6207\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SAFAEIAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Mahboobeh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"PORRAS, Carolina\";i:1;s:16:\"HERRERO, Rolando\";i:2;s:10:\"KEMP, Troy\";i:3;s:17:\"SHELTON, Gloriana\";i:4;s:10:\"QUINT, Wim\";i:5;s:18:\"VAN DOOM, Leen-Jan\";i:6;s:17:\"HILDESHEIM, Allan\";i:7;s:14:\"PINTO, Ligia A\";i:8;s:10:\"YUANJI PAN\";i:9;s:14:\"KREIMER, Aimee\";i:10;s:16:\"SCHILLER, John T\";i:11;s:15:\"GONZALEZ, Paula\";i:12;s:15:\"LOWY, Douglas R\";i:13;s:17:\"WACHOLDER, Sholom\";i:14;s:15:\"SCHIFFMAN, Mark\";i:15;s:16:\"RODRIGUEZ, Ana C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1158\/1940-6207.CAPR-13-0203\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Cancer prevention research (Philadelphia, Pa.)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Cancer prev. res. (Phila., Pa.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1242\";s:8:\"\u0000*\u0000epage\";s:4:\"1250\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1940-6207\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SAFAEIAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Mahboobeh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"PORRAS, Carolina\";i:1;s:16:\"HERRERO, Rolando\";i:2;s:10:\"KEMP, Troy\";i:3;s:17:\"SHELTON, Gloriana\";i:4;s:10:\"QUINT, Wim\";i:5;s:18:\"VAN DOOM, Leen-Jan\";i:6;s:17:\"HILDESHEIM, Allan\";i:7;s:14:\"PINTO, Ligia A\";i:8;s:10:\"YUANJI PAN\";i:9;s:14:\"KREIMER, Aimee\";i:10;s:16:\"SCHILLER, John T\";i:11;s:15:\"GONZALEZ, Paula\";i:12;s:15:\"LOWY, Douglas R\";i:13;s:17:\"WACHOLDER, Sholom\";i:14;s:15:\"SCHIFFMAN, Mark\";i:15;s:16:\"RODRIGUEZ, Ana C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1158\/1940-6207.CAPR-13-0203\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Cancer prevention research (Philadelphia, Pa.)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Cancer prev. res. (Phila., Pa.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1242\";s:8:\"\u0000*\u0000epage\";s:4:\"1250\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1940-6207\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SAFAEIAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Mahboobeh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"PORRAS, Carolina\";i:1;s:16:\"HERRERO, Rolando\";i:2;s:10:\"KEMP, Troy\";i:3;s:17:\"SHELTON, Gloriana\";i:4;s:10:\"QUINT, Wim\";i:5;s:18:\"VAN DOOM, Leen-Jan\";i:6;s:17:\"HILDESHEIM, Allan\";i:7;s:14:\"PINTO, Ligia A\";i:8;s:10:\"YUANJI PAN\";i:9;s:14:\"KREIMER, Aimee\";i:10;s:16:\"SCHILLER, John T\";i:11;s:15:\"GONZALEZ, Paula\";i:12;s:15:\"LOWY, Douglas R\";i:13;s:17:\"WACHOLDER, Sholom\";i:14;s:15:\"SCHIFFMAN, Mark\";i:15;s:16:\"RODRIGUEZ, Ana C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
